Bausch + Lomb Corporation (BLCO)

Market Cap	5.22B
Revenue (ttm)	4.15B
Net Income (ttm)	-260.00M
Shares Out	350.99M
EPS (ttm)	-0.74
PE Ratio	n/a
Forward PE	22.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,238
Open	14.71
Previous Close	14.90
Day's Range	14.70 - 14.91
52-Week Range	13.62 - 21.95
Beta	n/a
Analysts	Buy
Price Target	19.44 (+30.78%)
Earnings Date	May 1, 2024

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 6, 2022
• Employees: 13,300
• Stock Exchange: NYSE
• Ticker Symbol: BLCO

Analyst Forecast

According to 9 analysts, the average rating for BLCO stock is "Buy." The 12-month stock price forecast is $19.44, which is an increase of 30.78% from the latest price.

Price Target

$19.44

(30.78% upside)

Analyst Consensus: Buy